The Society for Immunotherapy of Cancer (SITC) is pleased to offer a second highly anticipated series of nine live webinars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.
Basic, clinical and translational researchers in academia and industry and members of the investment community.
View Registration Rates
All Deep Dive webinar recordings and slide content (contingent upon faculty permissions) will be posted in your SITC Library if you are registered for the seminar. To access the Enduring Materials, you must be logged into your SITC account.View Enduring Materials
If you have questions about this webinar series, please contact the SITC Education team.
Targets for Cancer IO: A Deep Dive Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, Merck & Co., Inc., and Regeneron Pharmaceuticals (as of 10/05/2021).Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com